SNT 2.86% 3.4¢ syntara limited

kalydeco and bronchitol, page-12

  1. 590 Posts.
    IMO I beleive Kalydeco may only be for a specific genetic strain of cf that inflicts 5% of the cf community. Bronchitol treats the cough symptom and appears to reduce exacerbations which results in costly hosiptalisations. B. appears to work very well in conjunction with Kalydeco. Bronchitol is really a substitute for hypertonic saline. Before B. cf patients needed to spend 2 hours a day on a ventilator, for many cf patients using B. they can move away from saline and do this aspect of their treatment in 5 minutes a day and can travel without needing to keep close to a fridge!

    I am not an expert on cf or the treatment options. I listen to the cf community who are the most knowledgable about treatment options and my comments are just me repeating what I think I hear.

 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.4¢
Change
-0.001(2.86%)
Mkt cap ! $43.87M
Open High Low Value Volume
3.5¢ 3.5¢ 3.4¢ $14.00K 402.4K

Buyers (Bids)

No. Vol. Price($)
3 440288 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 374403 3
View Market Depth
Last trade - 15.50pm 30/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.